Provisional deaths registration data for single year of age and average age of death (median and mean) of persons whose death involved coronavirus (COVID-19), England and Wales. Includes deaths due to COVID-19 and breakdowns by sex.

As of February 4, 2022, in the age group 75 to 84 years old COVID-19 was involved in the deaths of 32,780 males and 23,390 females in the United Kingdom. Furthermore, since the pandemic started over 72 thousand deaths in the UK among those aged 85 years and above involved COVID-19. For further information about the COVID-19 pandemic, please visit our dedicated Facts and Figures page.

As of July 30, 2020, there had been more confirmed cases of coronavirus (COVID-19) among women in England compared to men. The data shows that there are few confirmed cases among children, while there have been approximately nine thousand confirmed cases for both men and women aged 80 to 84 years.

As of July 30, there have been 302,301 confirmed coronavirus cases in the UK, and the regional breakdown of cases can be found here. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

As of February 17, 2022, there had been approximately 139.5 thousand deaths due to COVID-19 recorded in England. When broken down by age, almost 37 percent of these deaths occurred in the age group 80 to 89 years, while a further fifth of deaths were recorded among over 90 year olds. For further information about the COVID-19 pandemic, please visit our dedicated Facts and Figures page.

The number of deaths registered in England and Wales due to and involving coronavirus (COVID-19). Breakdowns include age, sex, region, local authority, Middle-layer Super Output Area (MSOA), indices of deprivation and place of death. Includes age-specific and age-standardised mortality rates.

COVID-19Plots and analysis relating to the coronavirus pandemic. Includes five sets of plots and associated R code to generate them.1) HeatmapsUpdated every few days - heatmaps of COVID-19 case and death trajectories for Local Authorities (or equivalent) in England, Wales, Scotland, Ireland and Germany.2) All cause mortalityUpdated on Tuesday (for England & Wales), Wednesday (for Scotland) and Friday (for Northern Ireland) - analysis and plots of weekly all-cause deaths in 2020 compared to previous years by country, age, sex and region. Also a set of international comparisons using data from mortality.org3) ExposuresNo longer updated - mapping of potential COVID-19 mortality exposure at local levels (LSOAs) in England based on the age-sex structure of the population and levels of poor health.There is also a Shiny app which creates slightly lower resolution versions of the same plots online, which you can find here: https://victimofmaths.shinyapps.io/covidmapper/, on GitHub https://github.com/VictimOfMaths/COVIDmapper and uploaded to this record4) Index of Multiple Deprivation No longer updated - preliminary analysis of the inequality impacts of COVID-19 based on Local Authority level cases and levels of deprivation. 5) Socioeconomic inequalities. No longer updated (unless ONS release more data) - Analysis of published ONS figures of COVID-19 and other cause mortality in 2020 compared to previous years by deprivation decile.Latest versions of plots and associated analysis can be found on Twitter: https://twitter.com/victimofmathsThis work is described in more detail on the UK Data Service Impact and Innovation Lab blog: https://blog.ukdataservice.ac.uk/visualising-high-risk-areas-for-covid-19-mortality/Adapted from data from the Office for National Statistics licensed under the Open Government Licence v.1.0.http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/

Estimates of the risk of hospital admission for coronavirus (COVID-19) and death involving COVID-19 by vaccination status, overall and by age group, using anonymised linked data from Census 2021. Experimental Statistics.

Outcome definitions

For this analysis, we define a death as involving COVID-19 if either of the ICD-10 codes U07.1 (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified) is mentioned on the death certificate. Information on cause of death coding is available in the User Guide to Mortality Statistics. We use date of occurrance rather than date of registration to give the date of the death.

We define COVID-109 hospitalisation as an inpatient episode in Hospital Episode Statistics where the primary diagnosis was COVID-19, identified by the ICD-19 codes (COVID-19, virus identified) or U07.2 (COVID-19, virus not identified). Where an individual had experienced more than one COVID-19 hospitalisation, the earliest that occurred within the study period was used. We define the date of COVID-19 hospitalisation as the start of the hospital episode.

ICD-10 code

U07.1 :

COVID-19, virus identified

U07.2:

COVID-19, virus not identified

Vaccination status is defined by the dose and the time since the last dose received

Unvaccinated:

no vaccination to less than 21 days post first dose

First dose 21 days to 3 months:

more than or equal to 21 days post second dose to earliest of less than 91 days post first dose or less than 21 days post second dose

First dose 3+ months:

more than or equal to 91 days post first dose to less than 21 days post second dose

Second dose 21 days to 3 months:

more than or equal to 21 days post second dose to earliest of less than 91 days post second dose or less than 21 days post third dose

Second dose 3-6 months:

more than or equal to 91 days post second dose to earliest of less than 182 days post second dose or less than 21 days post third dose

Second dose 6+ months:

more than or equal to 182 days post second dose to less than 21 days post third dose

Third dose 21 days to 3 months:

more than or equal to 21 days post third dose to less than 91 days post third dose

Third dose 3+ months:

more than or equal to 91 days post third dose

Model adjustments

Three sets of model adjustments were used

Age adjusted:

age (as a natural spline)

Age, socio-demographics adjusted:

age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status)

Fully adjusted:

age (as a natural spline), plus socio-demographic characteristics (sex, region, ethnicity, religion, IMD decile, NSSEC category, highest qualification, English language proficiency, key worker status), plus health-related characteristics (disability, self-reported health, care home residency, number of QCovid comorbidities (grouped), BMI category, frailty flag and hospitalisation within the last 21 days.

Age

Age in years is defined on the Census day 2021 (21 March 2021). Age is included in the model as a natural spline with boundary knots at the 10th and 90th centiles and internal knots at the 25th, 50th and 75th centiles. The positions of the knots are calculated separately for the overall model and for each age group for the stratified model.

This mapping tool enables you to see how COVID-19 deaths in your area may relate to factors in the local population, which research has shown are associated with COVID-19 mortality. It maps COVID-19 deaths rates for small areas of London (known as MSOAs) and enables you to compare these to a number of other factors including the Index of Multiple Deprivation, the age and ethnicity of the local population, extent of pre-existing health conditions in the local population, and occupational data. Research has shown that the mortality risk from COVID-19 is higher for people of older age groups, for men, for people with pre-existing health conditions, and for people from BAME backgrounds. London boroughs had some of the highest mortality rates from COVID-19 based on data to April 17th 2020, based on data from the Office for National Statistics (ONS). Analysis from the ONS has also shown how mortality is also related to socio-economic issues such as occupations classified ‘at risk’ and area deprivation. There is much about COVID-19-related mortality that is still not fully understood, including the intersection between the different factors e.g. relationship between BAME groups and occupation. On their own, none of these individual factors correlate strongly with deaths for these small areas. This is most likely because the most relevant factors will vary from area to area. In some cases it may relate to the age of the population, in others it may relate to the prevalence of underlying health conditions, area deprivation or the proportion of the population working in ‘at risk occupations’, and in some cases a combination of these or none of them. Further descriptive analysis of the factors in this tool can be found here: https://data.london.gov.uk/dataset/covid-19--socio-economic-risk-factors-briefing

Antibody data, by UK country and age, from the Coronavirus (COVID-19) Infection Survey.

Provisional age-standardised mortality rates for deaths due to COVID-19 by sex, local authority and deprivation indices, and numbers of deaths by middle-layer super output area.

Between January 1, 2021 and May 31, 2022, there were approximately 30.6 thousand deaths involving COVID-19 among 80 to 89 year olds in England, with over 14 thousand deaths occurring among unvaccinated people in this age group. Across all the age groups in the provided time interval, deaths involving COVID-19 among the unvaccinated population was around double the amount of people who received at least two doses of a vaccine. For further information about the COVID-19 pandemic, please visit our dedicated Facts and Figures page.

The COVID-19 Health Inequalities Monitoring in England (CHIME) tool brings together data relating to the direct impacts of coronavirus (COVID-19) on factors such as mortality rates, hospital admissions, confirmed cases and vaccinations.

By presenting inequality breakdowns - including by age, sex, ethnic group, level of deprivation and region - the tool provides a single point of access to:

• show how inequalities have changed during the course of the pandemic and what the current cumulative picture is
• bring together data in one tool to enable users to access and use the intelligence more easily
• provide indicators with a consistent methodology across different data sets to facilitate understanding
• support users to identify and address inequalities within their areas, and identify priority areas for recovery

In the March 2023 update, data has been updated for deaths, hospital admissions and vaccinations. Data on inequalities in vaccination uptake within upper tier local authorities has been added to the tool for the first time. This replaces data for lower tier local authorities, published in December 2022, allowing the reporting of a wider range of inequality breakdowns within these areas.

Please send any questions or comments to PHA-OHID@dhsc.gov.uk

According to a survey conducted in the United Kingdom (UK) in April 2022, **** percent of all people aged between 35 and 49 years reported to be suffering from long COVID symptoms, the highest share across all age groups. Furthermore, around *** percent of the population aged 50 to 69 years were estimated to suffer from long COVID. Overall, around *** thousand people in the UK reported their ability to undertake daily activities and routines was affected a little by long COVID symptoms.

Present state of COVID-19 As of May 2022, over ** million COVID-19 cases had been reported in the UK. The largest surge of cases was noted over the winter period 2021/22. The incidence of cases in the county since the pandemic began stood at around ****** per 100,000 population. Cyprus had the highest incidence of COVID-19 cases among its population in Europe at ****** per 100,000 people, followed by a rate of ****** in Iceland. Over *** thousand COVID-19 deaths have been reported in the UK. The deadliest day on record was January 20, 2021, when ***** deaths were recorded. In the UK, a COVID-19 death is defined as a person who died within ** days of a positive test.

Preventing long COVID through vaccination According to the WHO, being fully vaccinated alongside a significant proportion of the population also vaccinated is the best way to avoid the spread of COVID-19 or serious symptoms associated with the virus. It is therefore regarded that receiving a vaccine course as well as subsequent booster vaccines limits the chance of developing long COVID symptoms. As of April 27, 2022, around **** million first doses, **** million second doses, and **** booster doses had been administered in the UK.

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

As of July 17, 2022, it was estimated that around every person aged 75 to 79 years of age in England had received at least two doses of a COVID-19 vaccine. Although the source does mention that this is likely to be an overestimation due to population figures taken from 2020. The data shows that at least a quarter of men under 30 years of age have not yet had two vaccine doses, with women more likely to be vaccinated among younger age groups.

On March 4, 2020, the first death as a result of coronavirus (COVID-19) was recorded in the United Kingdom (UK). The number of deaths in the UK has increased significantly since then. As of January 13, 2023, the number of confirmed deaths due to coronavirus in the UK amounted to 202,157. On January 21, 2021, 1,370 deaths were recorded, which was the highest total in single day in the UK since the outbreak began.

Number of deaths among highest in Europe
The UK has had the highest number of deaths from coronavirus in western Europe. In terms of rate of coronavirus deaths, the UK has recorded 297.8 deaths per 100,000 population.

Cases in the UK The number of confirmed cases of coronavirus in the UK was 24,243,393 as of January 13, 2023. The South East has the highest number of first-episode confirmed cases of the virus in the UK with 3,123,050 cases, while London and the North West have 2,912,859 and 2,580,090 confirmed cases respectively. As of January 16, the UK has had 50 new cases per 100,000 in the last seven days.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Provisional counts of the number of deaths and age-standardised mortality rates involving the coronavirus (COVID-19), by occupational groups, for deaths registered between 9 March and 28 December 2020 in England and Wales. Figures are provided for males and females.

This dataset illustrates uptake inequalities of fourth doses of the coronavirus (COVID-19) vaccine using 2021 Census-derived demographic and socio-economic characteristics: age. sex, ethnicity, religion, socio-economic status and self-reported disability and health status.

Vaccination data are produced using linked data from Deaths registrations and Census 2021, National Immunisation Management Service, Hospital Episode Statistics and General Practise Extraction Service data for Pandemic Planning and Research.

Data may differ from weekly administrative vaccination data published by NHS England.